G2GBIO is addressing this challenge by advancing treatments for chronic diseases through our proprietary InnoLAMP (Innovative Long-Acting Microsphere Platform) technology. We are very proud that our unique approach ensures the production of high-quality, uniform microsphere injectables on a commercial scale. With InnoLAMP, G2GBIO is well-positioned to expand globally and continuously innovate, aiming to bring new, effective drugs to the market.

InnoLAMP TECHNOLOGY : G2GBIO developed a proprietary technology named InnoLAMP (Innovative Long-Acting Microsphere Platform) that overcomes the limitations of conventional manufacturing methods. Using InnoLAMP, G2GBio succeeded in producing competitive microspheres. InteLAMP TECHNOLOGY : It facilitates not only sustained release of drugs from microspheres but also uniform distribution of microspheres within the tumor tissue to selectively kill cancer cells

Private

Biotech